Condition

Drug Interactions clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Drug Interactions clinical trials that are recruiting, at sites in 2 countries (most in United States (2), Russia (1)). By phase: Phase 4 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Drug Interactions clinical trials

StudyPhaseWhereStatusRegistered
Optimizing LDL cholesterol levels using inclisiran for patients with drug interactions Phase 4 La Jolla, California Recruiting Mar 10, 2025
Examining interactions between opioids and benzodiazepines Phase 1/2 Lexington, Kentucky Recruiting Jan 3, 2025
Online survey to assess health risk factors and drug interactions — Tomsk Recruiting Dec 7, 2023

All recruiting trials (3)

Related topics

PolypharmacyCardiometabolic SyndromeCOVID-19Primary PreventionRisk Factors

Quick answers

How many Drug Interactions clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (2 trials), Russia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.